DOP2000000092A - COMBINATION CHEMOTHERAPY - Google Patents

COMBINATION CHEMOTHERAPY

Info

Publication number
DOP2000000092A
DOP2000000092A DO2000000092A DO2000000092A DOP2000000092A DO P2000000092 A DOP2000000092 A DO P2000000092A DO 2000000092 A DO2000000092 A DO 2000000092A DO 2000000092 A DO2000000092 A DO 2000000092A DO P2000000092 A DOP2000000092 A DO P2000000092A
Authority
DO
Dominican Republic
Prior art keywords
combination chemotherapy
combination
chemotherapy
acetyldinaline
carboplatin
Prior art date
Application number
DO2000000092A
Other languages
Spanish (es)
Inventor
Wayne Daniel Klohs
Ronald Lynn Merriman
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to DO2000000092A priority Critical patent/DOP2000000092A/en
Publication of DOP2000000092A publication Critical patent/DOP2000000092A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La acetildinalina en combinación con paclitaxel y/o carboplatina es sinergistica para tratar el cáncerAcetyldinaline in combination with paclitaxel and / or carboplatin is synergistic to treat cancer

DO2000000092A 2000-11-09 2000-11-09 COMBINATION CHEMOTHERAPY DOP2000000092A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2000000092A DOP2000000092A (en) 2000-11-09 2000-11-09 COMBINATION CHEMOTHERAPY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2000000092A DOP2000000092A (en) 2000-11-09 2000-11-09 COMBINATION CHEMOTHERAPY

Publications (1)

Publication Number Publication Date
DOP2000000092A true DOP2000000092A (en) 2002-03-30

Family

ID=44260986

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2000000092A DOP2000000092A (en) 2000-11-09 2000-11-09 COMBINATION CHEMOTHERAPY

Country Status (1)

Country Link
DO (1) DOP2000000092A (en)

Similar Documents

Publication Publication Date Title
AR028296A1 (en) SYNERGISTIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
FR2869231B1 (en) THERAPEUTIC COMPOSITION CONTAINING AT LEAST ONE PYRROLOBENZODIAZEPINE DERIVATIVE AND FLUDARABINE
CR11486A (en) TREATMENT OF UTERINE CANCER AND OVARIO CANCER WITH A PARP INHIBITOR ONLY OR IN COMBINATION WITH ANTI-TUMOR AGENTS
UY28213A1 (en) NEW CYANOPIRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS.
EP1622608A4 (en) Compositions and methods for treating cancer
MXPA05012421A (en) Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents.
AR048819A1 (en) SYNERGIC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
MX2010006991A (en) Therapeutic cancer treatments.
AR044039A1 (en) ANTINEOPLASIC COMBINATIONS
PA8506201A1 (en) COMBINATION CHEMOTHERAPY (COMBINATION CHEMOTHERAPY)
BRPI0507463A (en) use of glufosfamide and gemcitabine, product, and, combination of glufosfamide and gemcitabine
NO20050640L (en) Ruthenium anticancer complexes
HRPK20041072B3 (en) Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
EA200200808A1 (en) MODIFIED CYTOKINES INTENDED FOR USE IN CANCER TREATMENT
BR0114430A (en) Processes for cancer cell death induction and tumor regression
ES2185323T3 (en) USE OF ERYTHROPOIETIN IN THE TREATMENT OF MULTIPLE MYELOMA.
DE602004014787D1 (en) ANTI-TUMORAL FORMULATIONS WITH DEFIBROTIDE ALONE OR IN COMBINATION WITH OTHER ANTITUMOROUS AGENTS
DOP2000000092A (en) COMBINATION CHEMOTHERAPY
ECSP003755A (en) COMBINATION CHEMOTHERAPY
TR200302193T4 (en) Combination chemotherapy.
AR029451A1 (en) A COMPOSITION FOR USE IN THE BREAST CANCER THERAPY IN HUMAN BEINGS AND A PRODUCT FOR USE IN SUCH THERAPY
AR029958A1 (en) USE OF STRAMUSTIN PHOSPHATE IN THE TREATMENT OF OSEA METASTASIS AND IN THE TREATMENT OF OSEA METASTASIS IN PATIENTS WITH PROSTATE CANCER
ATE299028T1 (en) TREATMENT OF CANCER DISEASES WITH APLIDINE IN COMBINATION WITH CARNITINE OR ACETYLCARNITINE
BRPI0417513A (en) chp-gemcitabine combined agents and their use as active antitumor substances
MXPA04000418A (en) Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines.